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A B S T R A C T
Various forms of mercury possess different rates of absorption, metabolism and excretion, and
consequently, toxicity. Methylmercury (MeHg) is a highly neurotoxic organic mercurial. Human
exposure is mostly due to ingestion of contaminated ﬁsh. Ethylmercury (EtHg), another organic mercury
compound, has received signiﬁcant toxicological attention due to its presence in thimerosal-containing
vaccines. This study was designed to compare the toxicities induced by MeHg and EtHg, as well as by
their complexes with cysteine (MeHg-S-Cys and EtHg-S-Cys) in the C6 rat glioma cell line. MeHg and
EtHg caused signiﬁcant (p < 0.0001) decreases in cellular viability when cells were treated during
30 min with each mercurial following by a washing period of 24 h (EC50 values of 4.83 and 5.05 mM,
respectively). Signiﬁcant cytotoxicity (p < 0.0001) was also observed when cells were treated under the
same conditions with MeHg-S-Cys and EtHg-S-Cys, but the respective EC50 values were signiﬁcantly
increased (11.2 and 9.37 mM). L-Methionine, a substrate for the L-type neutral amino acid carrier
transport (LAT) system, signiﬁcantly protected against the toxicities induced by both complexes (MeHg-
S-Cys and EtHg-S-Cys). However, no protective effects of L-methionine were observed against MeHg and
EtHg toxicities. Corroborating these ﬁndings, L-methionine signiﬁcantly decreased mercurial uptake
when cells were exposed to MeHg-S-Cys (p = 0.028) and EtHg-S-Cys (p = 0.023), but not to MeHg and
EtHg. These results indicate that the uptake of MeHg-S-Cys and EtHg-S-Cys into C6 cells is mediated, at
least in part, through the LAT system, but MeHg and EtHg enter C6 cells by mechanisms other than LAT
system.
 2013 Elsevier Inc. All rights reserved.
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NeuroToxicology1. Introduction
Mercury is a highly toxic heavy metal present in the
environment due to both natural processes and anthropogenic
activities. It can be found mainly in three different forms:
elemental mercury (Hg0), inorganic mercury salts (Hg2+) and* Corresponding authors at: Departamento de Bioquı´mica, Centro de Cieˆncias
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http://dx.doi.org/10.1016/j.neuro.2013.05.015organic mercury (Clarkson et al., 2003). Methylmercury (MeHg), an
organic mercury compound, originates from methylation of
inorganic mercury by sulfate-reducing bacteria in aquatic envi-
ronment. Once in the aquatic food chain, MeHg bio-accumulates
and magniﬁes, reaching high levels in predatory ﬁsh, thus
representing a toxicological concern for humans subsiding on ﬁsh
for their dietary intake (Hintelmann, 2010).
MeHg is the most toxic form of mercury in the environment
(Clarkson and Magos, 2006) and despite its vast distribution
among several tissues after absorption, the central nervous system
(CNS) represents the main target of its toxicity, especially when
exposures occur during early stages of neurodevelopment (Farina
et al., 2011a). Although the molecular mechanisms by which MeHg
L.T. Zimmermann et al. / NeuroToxicology 38 (2013) 1–82enters the brain and exerts its toxicity have not been clearly
elucidated (Simmons-Willis et al., 2002), several studies point to
the high afﬁnity of MeHg for thiols (-SH) and selenols (-Se) as the
basis of their toxicity (Farina et al., 2009; Stringari et al., 2008; Rush
et al., 2012a,b). With respect to MeHg’s transport from blood to the
brain, it has been generally assumed that it occurs due to simple
diffusion (Simmons-Willis et al., 2002). However, several studies
have postulated that its transport from the blood to the CNS across
the blood–brain barrier (BBB) occurs, at least in part, through the L-
type neutral amino acid carrier transport (LAT) system (Aschner
et al., 1990; Kajiwara et al., 1996; Clarkson et al., 2007; Yin et al.,
2008) and that MeHg is transported as a MeHg-cysteine (MeHg-S-
Cys) complex. Indeed, Hg uptake into brain after injection of
MeHg-S-Cys complex was higher when compared with MeHg
alone (Kerper et al., 1992). Interestingly, this uptake was partially
inhibited by methionine, a substrate for the LAT system and the
uptake of methionine was also inhibited by the MeHg-S-Cys
complex, but not by MeHg alone (Kerper et al., 1992). Consistent
with these observations, over-expression of LAT-1 (an important
LAT subtype) in different cell lines increased Hg uptake, when
MeHg-S-Cys was administrated, whereas knockdown of LAT-1
reduced the uptake of MeHg-S-Cys and attenuated its cytotoxicity
(Simmons-Willis et al., 2002; Yin et al., 2008). Moreover, in vivo
studies showed that the administration of MeHg-S-Cys complex
caused a signiﬁcant increase in Hg accumulation in brain (cortex
and cerebellum) and liver compared with MeHg-treated mice
(Roos et al., 2010). These ﬁndings corroborate the hypothesis that
MeHg is transported as a complex with Cys (MeHg-S-Cys), by a
mechanism of molecular mimicry with the amino acid L-
methionine, one of the endogenous substrates of LAT-1 (Ballatori,
2002; Bridges and Zalups, 2010).
Another organic mercurial that has received signiﬁcant
toxicological attention is ethylmercury (EtHg), which shares with
MeHg some speciﬁc chemical and toxic properties (Mutkus et al.,
2005). In the early 1930s, ethylmercury thiosalicylate, known as
thimerosal, was introduced as a preservative in many medicinal
preparations and vaccines (Pless and Risher, 2000). Experimental
studies indicate that animal exposure to thimerosal-Hg (which
spontaneously generates EtHg and thiosalicylate in aqueous
medium) can lead to accumulation of inorganic Hg in brain (for
a review, see Do´rea, 2011). Although it is known that thimerosal
causes signiﬁcant neurotoxicity in experimental (in vitro and in
vivo) models, in vivo data indicate its shorter half-life compared
with MeHg (Burbacher et al., 2005), which explains its lower
neurotoxic potency. Accordingly, some studies on the potential
neurotoxic effects of thimerosal in humans have failed to report
adverse neurodevelopmental outcomes (Aschner and Ceccatelli,
2010; Do´rea, 2010).
As previously described, MeHg-induced toxicity is mediated by
its interaction with thiol groups (Aschner and Syversen, 2005;
Franco et al., 2009) and the interaction of MeHg with the sulfhydryl
amino acid cysteine is important for its entrance into the CNS (as a
MeHg-S-Cys complex), via speciﬁc amino acid transporters, such as
LAT-1 (Mokrzan et al., 1995; Heggland et al., 2009; Farina et al.,
2011b). On the other hand, although it is well known that EtHg
may share some chemical and toxic properties with MeHg (Mutkus
et al., 2005) and that it interacts with thiols, there are no studies
investigating its potential interaction with cysteine and the
formation of an EtHg-S-Cys type complex, as well as its potential
toxicity and transport via the LAT system. Thus, the aim of the
present study was to compare the toxicities induced by MeHg and
EtHg, as well as the products of their complexation with cysteine
(MeHg-S-Cys and EtHg-S-Cys) in the C6 rat glioma cell line. To
investigate the possible role of the LAT system in these processes, L-
Met (a well known LAT-1 substrate) was used to elucidate
potential mechanisms of toxicity, transport and protection.2. Materials and methods
2.1. Chemicals
Reduced glutathione, methylmercuric (II) chloride, ethylmer-
curic chloride and L-methionine were obtained from Sigma (St.
Louis, MO, USA). Rabbit polyclonal IgG anti-LAT-1 (sc-134994),
monoclonal anti-b-actin primary antibody and protein A/G
horseradish peroxidase-conjugated secondary antibody were from
Santa Cruz (Santa Cruz, CA). Dulbecco’s modiﬁed Eagle’s medium
(DMEM) and fetal bovine serum (FBS) were purchased from Gibco
(Gibco Life Technologies Inc.). All other chemicals were of the
highest commercially available grade.
2.2. Cell culture and treatments
C6 rat glioma cells (CCL-107) were obtained from the American
Type Culture Collection (http://www.atcc.org) and cultured as a
monolayer in polystyrene dishes and maintained in DMEM
supplemented with 2 mM glutamine, 100 units/mL, penicillin,
100 mg/mL streptomycin and 10% fetal bovine serum (FBS) at 37 8C
in a humidiﬁed atmosphere of 5% CO2. Cells were subcultured at
80% conﬂuence and used between the 10th and 16th passage.
Twenty-four hours after plating (conﬂuence 80%), cells were
washed with Hank’s balanced salt solution (HBSS; 135 mM NaCl,
20 mM HEPES, 4 mM KCl, 1 mM Na2HPO4, 2 mM CaCl2, 1 mM
MgCl2, 10 mM glucose) and incubated for 30 min with MeHg, EtHg
or their Cys complexes (MeHg-S-Cys or EtHg-S-Cys) at concentra-
tions ranging from 100 nM to 30 mM. MeHg-S-Cys and EtHg-S-Cys
were synthesized by direct reaction of the mercurials with L-
cysteine in water for 1 h. To ensure the absence of free mercurials
in the complex solutions, the molar ratio of cysteine to MeHg and
EtHg was 1.15 and the total complexation was conﬁrmed by
measuring free thiols with the Ellman’s reagent (Ellman, 1959).
Treatments with the compounds (MeHg, EtHg or their complexes
with Cys) were performed in a sulfhydryl molecule-free medium
during 30 min. The short-time treatment with the mercurials
(30 min) was chosen based on the relative fast kinetics of
mercurials’ entrance into the cells. In some experiments, L-
methionine (a substrate for the L-type neutral amino acid carrier
transport system) was added to the incubation medium (HBSS)
15 min before the mercurial’s addition at a ﬁnal concentration
1000 fold greater than the Hg-compounds; this amino acid
remained in this medium during the mercurial’s treatment
(30 min), totaling 45 min. After the short-time (30 or 45 min)
treatments with the mercurials and/or L-methionine, the HBSS was
replaced by fresh DMEM. Cells were placed on the 5% CO2
atmosphere (at 37 8C), where they were maintained for different
periods before the evaluation of cell viability (24 h), glutathione
levels (4 h) and Hg levels (30 min). Consequently, after a constant
period (30 min) of exposure to each mercurial, the evaluations of
Hg levels (item 2.3), glutathione levels (item 2.4) and cell viability
(item 2.5) were purposely performed at different time-points
(30 min, 4 h and 24 h, respectively) in an attempt to better
understand the sequence of relevant events (mercurial’s entrance
into cells, glutathione oxidation and disruption of cellular
viability).
2.3. Hg levels in cells
Thirty minutes after mercurial’s treatment, mercury (Hg)
measurements were carried out with a quadrupole inductively
coupled plasma mass spectrometer (ICP-MS ELAN DRCII, Perki-
nElmer, SCIEX, Norwalk, CT, USA) coupled with a Perkin Elmer
model L-200 LC pump, six-port injector (Rheodyne 9725) with a
reverse-phase column (C18, 5 mm, 150 mm  4 mm, Brownlee
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RP18 (7 mm, 15 mm  3.2 mm, Brownlee Columns PerkinElmer
(USA)). The methodology allows the detection of different species
of mercurials, such as MeHg, EtHg and inorganic mercury.
Instrument settings and operative conditions have been previously
reported (Rodrigues et al., 2010).
2.4. Glutathione levels
Four hours after the 30 min mercurial’s treatment, GSH levels
were measured as non-protein thiols based on the protocol
developed by Ellman (1959). In short, the cells suspensions were
precipitated in cooled trichloroacetic acid 10% and centrifuged at
5000  g for 10 min, and the supernatant was incubated with 5,50-
dithiobis(2-nitrobenzoic acid) (DTNB) in a 1 M phosphate buffer,
pH 7.0. Absorbance was measured at 412 nm. A standard curve of
reduced GSH was used to calculate control cell GSH levels; the
results of the other groups were expressed as percentage of
control.
2.5. Cell viability assay
Twenty-four hours after the 30 min mercurial’s treatment, cell
viability was evaluated based on the reduction of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT
assay) (Vendrell et al., 2007) and on the leakage of lactate
dehydrogenase into the cultured medium (Farina et al., 2009).
Results of the MTT assays were expressed as percentage of control
values (non-treated cells) after subtracting the blank values. All
experiments were performed in triplicate.
2.6. Western blot analyses
Cells were rinsed with PBS and collected in ice-cold lysis buffer
(50 mM Tris–HCl (pH 7.5), 1% Triton X-100, 100 mM NaCl, 5 mM
EDTA (pH 8.0), 40 mM b-glycerolphosphate, 50 mM NaF, 200 mM
orthovanadate, 5% glycerol and protease inhibitors), sonicated for
5 min and centrifuged at 14,000  g for 45 min at 4 8C. As controls,
tissue samples were obtained from mouse (heart) and rat
(hippocampus). The tissues were homogenized (1:10, w/v) in
ice-cold lysis buffer. All the homogenates (tissues and cells) were
centrifuged at 14,000  g, at 4 8C for 45 min, equivalent amounts of
proteins were mixed in buffer (Tris 200 mM, glycerol 10%, SDS 2%,
b- mercaptoethanol 2.75 mM and bromophenol blue 0.04%),
boiled for 5 min and cooled immediately on ice. Samples (40 mg
of protein) were subjected to SDS polyacrylamide gel electropho-
resis on 10% polyacrylamide gels. Gels were run at 30 mA for about
120 min, with the electrophoresis tank placed in an iced water
bath. Separated proteins were electroblotted onto nitrocellulose
membranes at a constant current intensity of 400 mA for 90 min.
The membranes were blocked for 1 h at room temperature in
blocking buffer containing 5% nonfat dry milk. Blots were
incubated overnight at 4 8C with primary polyclonal antibody
against LAT-1 (1:500) in TBS–Tween–BSA buffer (20 mM Tris base,
140 mM NaCl, 0.05% Tween-20, 5% BSA). After washing, the blots
were incubated for 1 h at room temperature with protein A/G-
horseradish peroxidase conjugate (1:5000) in TBS–Tween buffer.
Then, membranes were washed and developed with Immun-Star
HRP Chemiluminescent reagents (Bio-Rad, Hercules, CA), and
chemiluminescence was viewed with the Versadoc Imaging
system (Bio-Rad). b-Actin was used as loading control. As negative
and positive controls for LAT-1 expression, we used heart and
hippocampus, respectively (Kanai et al., 1998; Boado et al., 1999).
The mouse heart and rat hippocampus were derived from animals
related to other ongoing studies from our laboratory, which were
in accordance with the Guiding Principles of the Animal Care andWellness Committee of the Universidade Federal de Santa Catarina
(CEUA/UFSC PP00424 and PP00326).
2.7. Statistical analysis
The results were analyzed with the STATISTICA software system
(version 8.0; StatSoft, Inc., 2008) and graphed with GraphPad Prism
for Windows (version 5.0; GraphPad Software, San Diego, CA). For
the concentration–response studies, signiﬁcant differences were
evaluated by one-way analysis of variance (ANOVA). Two-way
ANOVA was performed to evaluate signiﬁcant L-Met by mercurials’
interactions. After signiﬁcant ANOVAs, Tukey’s multiple compari-
son test was performed and the differences were considered
signiﬁcant when p < 0.05. Results are expressed as mean  SEM,
except for the EC50 values and Hg levels, which are expressed as mean
and 95% conﬁdence intervals and standard deviation (SD), respec-
tively. Pearson correlations were performed to evaluate the relation-
ships between MTT reduction and LDH leakage.
3. Results
3.1. Concentration–response studies
Fig. 1 shows the toxicity of the studied mercury compounds in
C6 cells, when mercurials were incubated during 30 min in a
sulfhydryl-free incubating medium. After 24 h, signiﬁcant
decreases in cellular viability were observed after MeHg and EtHg
exposures [half maximal effective concentration (EC50) values of
4.83 mM (4.34–5.33; 95% conﬁdence intervals) and 5.05 mM
(3.87–6.23; 95% conﬁdence intervals), respectively] (Fig. 1A and
B). Signiﬁcant cell toxicities were also observed when cells were
treated under the same conditions with the products of mercurial
complexation with cysteine (MeHg-S-Cys and EtHg-S-Cys);
however, the respective EC50 values were signiﬁcantly
(p < 0.001) increased [11.2 mM (9.81–12.59; 95% conﬁdence
intervals) and 9.37 mM (8.81–9.93; 95% conﬁdence intervals)]
(Fig. 1A and B). The EC50 values of MeHg and EtHg were not
statistically different (Table 1), but MeHg and EtHg were
signiﬁcantly (p < 0.001) more toxic than their respective com-
plexes (MeHg-S-Cys and EtHg-S-Cys).
In order to evaluate if an inhibition of cell division could
potentially account for the signiﬁcant decreased MTT metabolism
observed in mercurial-treated cells (Fig. 1), we performed
additional studies using an alternative test to evaluate cell
viability, namely, lactate dehydrogenase (LDH) leakage (Farina
et al., 2009). LDH is a soluble cytosolic enzyme present in most
eukaryotic cells; it is released into the culture medium upon cell
death due to damage or rupture of plasma membrane. Thus, the
increase of LDH activity in culture medium is proportional to the
number of lysed cells, an event that is not affected by decreased cell
division. Cells were treated with different mercurial concentra-
tions (0–10 mM) similarly to Fig. 1 conditions and, 24 h after
treatments, LDH activity was measured in the culture medium
while MTT reduction was measured in the platted cells. Correlation
analyses showed signiﬁcant negative correlations between LDH
activity (measured in the culture medium) and MTT reduction
(Supplemental File 1), which indicates that the decreased MTT
metabolism observed in mercurial-treated cells is not related to
inhibitory effects toward cell division.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.neuro.2013.05.015.
3.2. Effect of L-Met on the toxicity of Hg compounds
The second set of experiments was designed to investigate the
effects of L-Met (a well known substrate of the LAT-1 transporter)
MeHg 4.5 µ Cys-MeHg 12 M µM
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Fig. 1. Dose–response curve of mercurial-induced cell toxicity. Rat glioma C6 cells (80% conﬂuence) were treated with (A) MeHg or MeHg-Cys, (B) EtHg or EtHg-Cys in HBSS.
After 30 min of mercurial’s treatment, HBSS was replaced by fresh DMEM and the cells were incubated for additional 24 h at 37 8C in a humidiﬁed atmosphere of 5% CO2.
Results of the MTT assays were expressed as percentage of control values (non treated cells). *p < 0.05 and ***p < 0.001 when compared to controls by one-way ANOVA
followed by the Tukey’s HSD test. Data are expressed as mean  SEM (N = 3 independent experiments).
L.T. Zimmermann et al. / NeuroToxicology 38 (2013) 1–84pre-treatment on the toxicity induced by MeHg and EtHg, as well
as their respective complexes with Cys. The concentrations of the
studied mercurials were near the EC50 values calculated by non-
linear regression (sigmoidal concentration–response curves) from
Fig. 1 data. L-Met (12 mM), added 15 min prior to the mercurial’s
addition, signiﬁcantly protected C6 cells from MeHg-S-Cys
(12 mM) induced cell death, but no signiﬁcant protective effects
were observed in the presence of this amino acid when the cells
were treated with 4.5 mM MeHg alone (Fig. 2A). In addition, L-Met
(10 mM), also added 15 min prior to the mercurial’s addition,
signiﬁcantly protected C6 cells from EtHg-S-Cys (10 mM) induced
cell death, but no signiﬁcant protective effects of L-Met were
observed when the cells were treated with 6 mM EtHg alone
(Fig. 2B).
3.3. Effect of L-Met on intracellular Hg levels
Corroborating the ﬁndings on the protective effects of L-Met
against MeHg-S-Cys- and EtHg-S-Cys-induced cytotoxicity (Fig. 2),
this amino acid (added 15 min prior to the mercurial’s addition)
caused a signiﬁcant decrease in total Hg accumulation in cells
incubated with MeHg-S-Cys and EtHg-S-Cys (Table 2). However,Table 1
EC50 values of mercurial-induced cell death.
EC50mM (95%CI)
MeHg EtHg
Mercurial alone 4.83 (4.34–5.33) 5.05 (3.87–6.23)
Mercurial-Cys complex 11.20 (9.81–12.59)* 9.37 (8.81–9.93)#,+
EC50 values were determined by non-linear regression (sigmoidal concentration–
response curves) from Fig. 1 data. EC50 values are expressed as mean and 95%
conﬁdence intervals (CI).
* p < 0.001 when compared to MeHg.
# p < 0.001 when compared to EtHg.
+ p < 0.01 when compared to MeHg-S-Cys.
EtHg 6 µ Cys-EtHg 10 M µM
Fig. 2. Effect of L-methionine on mercurial-induced cell toxicity. Rat C6 glioma cells
were pre-treated with L-Met (at ﬁnal concentrations 1000 fold greater than those of
the respective Hg-compound) for 15 min before treatment with (A) MeHg (4.5 mM)
or MeHg-Cys (12 mM), (B) EtHg (6 mM) or EtHg-Cys (10 mM) in HBSS. Thus, the
concentrations of L-Met were 4.5 mM, 12 mM, 6 mM or 10 mM in wells treated with
MeHg, MeHg-Cys, EtHg or EtHg-Cys, respectively. After the exposure to mercurials
(30 min), HBSS was replaced by fresh DMEM and the cells were incubated for
additional 24 h. Results of the MTT assays were expressed as percentage of control
values (dashed line). The asterisks (*) mean signiﬁcant differences (p < 0.001) when
compared to control and the symbol + means signiﬁcant difference (p < 0.001)
when compared to cells treated only with the respective mercurial (without Cys) by
two-way ANOVA followed by the Bonferroni test. Data are expressed as
mean  SEM (N = 6–9 independent experiments).
Table 2
Effects of L-methionine (L-Met) on total mercury concentration in C6 cells treated with MeHg, EtHg and their cysteine-complexes (MeHg-Cys and EtHg-Cys).
Mercurial L-Met Total mercury concentration (ng/mL)
MeHg MeHg-Cys EtHg EtHg-Cys
+  7.28 (0.274)* 5.12 (1.101)* 5.35 (0.274)* 3.72 (0.357)*
+ + 7.87 (1.101)* 2.08 (0.606)*,# 5.96 (0.523)* 2.71 (0.165)*,#
  0.0098 (0.0027)
 + 0.0118 (0.0035)
Rat C6 glioma cells were pre-treated with 7 mM L-Met for 15 min before treatment with MeHg, EtHg, MeHg-Cys or EtHg-Cys (7 mM) in HBSS. After the exposure to mercurials
(30 min), cells were washed twice with HBSS and, after 30 min, harvested in 200 mL Milli-Q water for mercury quantiﬁcation. Data are expressed as ng Hg/mL of sample and
represented as mean  SD (N = 2 independent experiments).
* Signiﬁcantly different (p < 0.05) from control cells (no mercurial treatment) by two-way ANOVA followed by the Tukey’s HSD test.
# Signiﬁcantly different (p < 0.05) from cells treated only with the respective mercurial (no L-Met treatment) by two-way ANOVA followed by the Tukey’s HSD test.
L.T. Zimmermann et al. / NeuroToxicology 38 (2013) 1–8 5no signiﬁcant effects of L-Met were observed when cells were
incubated with MeHg and EtHg (Table 2).
In cells treated with MeHg, a signiﬁcant MeHg effect
[F(1,4) = 347.77; p = 0.00005] was observed on intracellular Hg
levels, although L-Met showed no signiﬁcant effects [F(1,4) = 0.53;
p = 0.506]. Moreover, no signiﬁcant MeHg by L-Met interaction
[F(1,4) = 0.52; p = 0.508] was detected (Table 2). Notably, in cells
treated with MeHg-S-Cys, signiﬁcant MeHg-S-Cys [F(1,4) = 63.89;
p = 0.0013] and L-Met [F(1,4) = 11.37; p = 0.0280] effects were
observed. In addition, a signiﬁcant MeHg-S-Cys by L-Met interac-
tion [F(1,4) = 11.39; p = 0.0279] was detected, corroborating the
signiﬁcant decrease in Hg levels in cells treated with MeHg-S-Cys
plus L-Met compared with cells treated with MeHg-S-Cys alone
(Table 2).
In cells treated with EtHg, a signiﬁcant EtHg effect
[F(1,4) = 714.43; p = 0.00001] was observed on Hg levels, but L-
Met showed no signiﬁcant effects [F(1,4) = 2.09; p = 0.22]. No
signiﬁcant EtHg by L-Met interaction [F(1,4) = 2.07; p = 0.22] was
observed (Table 2). Conversely, in cells treated with EtHg-S-Cys,
signiﬁcant EtHg-S-Cys [F(1,4) = 518.07; p = 0.00002] and L-MetMeHg 4.5 μM Cys-MeHg 12 μM 
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Fig. 3. Glutathione levels after mercurial exposure. Rat C6 glioma cells were treated
with MeHg, MeHg-Cys (A), EtHg, or EtHg-Cys (B) in HBSS (at concentrations
approximating their respective EC50 value in the toxicity assay – Fig. 1). L-
Methionine was added to the incubation medium (HBSS) 15 min before the
mercurial’s addition at a ﬁnal concentration 1000 fold greater than the Hg-
compounds. After 30 min, HBSS was replaced by fresh DMEM and the cells were
incubated for additional 4 h at 37 8C in a humidiﬁed atmosphere of 5% CO2. GSH
concentration in control C6 cells (non treated) was 69.0  2.2 nmol of GSH/mg of
protein. GSH levels are expressed as percentage of control values (100%, dashed line).
The asterisks (*) mean signiﬁcant differences (p < 0.01) when compared to control and
the symbol + means signiﬁcant difference (p < 0.05) when compared to cells treated
only with the respective mercurial (without Cys) by two-way ANOVA followed by the
Bonferroni test. Data are expressed as mean  SEM (N = 4 independent experiments).[F(1,4) = 12.63; p = 0.023] effects were observed. A signiﬁcant
EtHg-S-Cys by L-Met interaction [F(1,4) = 12.73; p = 0.023] was
detected, corroborating the signiﬁcant reduction in Hg levels in
cells treated with EtHg-S-Cys plus L-Met compared with cells
treated with EtHg-S-Cys alone (Table 2).
In addition to the total Hg levels, speciation analyses were also
performed. No MeHg was detected in cells treated with EtHg and
EtHg-S-Cys. Moreover, no EtHg was detected in cells treated with
MeHg and MeHg-S-Cys. Approximately 0.1% of the total mercury
was in the inorganic form in cells treated with MeHg or MeHg-S-
Cys (data not shown). In contrast, approximately 1% (10 fold
higher) of the total mercury was in the inorganic form in cells
treated with EtHg or EtHg-S-Cys (data not shown), in agreement
with the higher dealkylation rate of EtHg compared with MeHg
(Burbacher et al., 2005).
3.4. Glutathione levels
GSH is the most abundant intracellular non-protein thiol
present in mammalian cells. In this study, we evaluated GSH levels
in C6 cells after exposure to MeHg, EtHg and their complexes,
MeHg-S-Cys and EtHg-S-Cys (Fig. 3). Moreover, we also evaluated
the effect of L-Met pre-treatment at a ﬁnal concentration 1000 fold
greater than the Hg-compounds. The results clearly indicate that
all the studied mercurials signiﬁcantly reduced intracellular GSH
levels at 4 h after the 30 min mercurial exposure. No differences in
GSH levels were observed between cells treated with MeHg and
EtHg (at concentrations approximating their respective EC50 values
in the toxicity assay). In addition, no differences were found
between cells treated with MeHg-S-Cys and EtHg-S-Cys (at
concentrations approximating their respective EC50 values in the
toxicity assay). The pre-treatment with L-Met was able to protect
against GSH reduction only when the cells were incubated with the
complexes (MeHg-S-Cys and EtHg-S-Cys).
3.5. Western blot analysis of LAT-1
We performed western blot analyses in order to investigate
whether our cellular model (C6 rat glioma cells) expresses LAT-1.
Fig. 4 clearly indicates the presence of LAT-1 in C6 cells and rodent
hippocampus (positive control), although LAT-1 levels were notFig. 4. Western blot analysis of LAT-1 from different sources. Homogenates from rat
glioma C6 cells, rat hippocampus (hippo; positive control) or mouse hearth
(negative control) were submitted to SDS polyacrylamide gel electrophoresis,
electroblotted and incubated overnight with primary polyclonal antibody against
LAT-1 (1:500). b-Actin bands are also shown (protein load control).
L.T. Zimmermann et al. / NeuroToxicology 38 (2013) 1–86detected in rodent heart tissue (negative control), corroborating
prior ﬁndings (Kanai et al., 1998; Boado et al., 1999).
4. Discussion
In this study, we observed that MeHg-S-Cys and EtHg-S-Cys,
but not MeHg and EtHg, are substrates for the LAT transporter
system in the C6 glioma cell line. Thus, this transporter plays a
signiﬁcant role in modulating the entry of cysteinyl-complexes of
MeHg and EtHg (MeHg-S-Cys and EtHg-S-Cys) into glial cells. This
event is of physiological signiﬁcance, given that in biological
systems mercurials are primarily bound to thiols. Conversely,
MeHg and EtHg entry into C6 glioma cells is modulated by
mechanism(s) distinct of the LAT system (not affected by L-Met),
potentially involving simple diffusion (Simmons-Willis et al.,
2002) or interaction with membrane sulfhydryl proteins and
subsequent exchange reactions with intracellular thiols (Raben-
stein et al., 1982; Farina et al., 2011a). Interestingly, intracellular
Hg concentrations were higher in cells treated with MeHg or EtHg
compared with those treated with equimolar concentrations of
their respective complexes, MeHg-S-Cys or EtHg-S-Cys (Table 2).
Taking into account that (i) cells were exposed to mercurials in a
sulfhydryl-free medium, and that (ii) MeHg and EtHg entry into
cells did not require the LAT system (was not affected by L-Met),
these results indicate that transport mechanisms other that the
LAT system signiﬁcantly contribute to the entry of both MeHg and
EtHg into cells. Moreover, because a 1000 fold higher concentra-
tion of L-Met was ineffective in fully preventing mercurial entry
into cells treated with MeHg-S-Cys and EtHg-S-Cys, it is likely that
these cysteinyl-complexes utilize different protein transporters or,
alternatively, release the free mercurials into the extracellular
milieu, allowing for their entry into cells via other mechanisms,
such as simple diffusion or exchange thiol reactions.
Signiﬁcant decreases in cellular viability were observed after
MeHg and EtHg exposures. Notably, signiﬁcant cell toxicities were
also observed when cells were treated with MeHg-S-Cys and EtHg-
S-Cys, although their respective EC50 values were increased (Fig. 1A
and B). Based on the cellular viability test and the intracellular Hg
levels, it is reasonable to suppose that both MeHg and EtHg exhibit
analogous toxicities in rat glioma C6 cells under in vitro conditions.
The inherently lower toxicities of MeHg-S-Cys or EtHg-S-Cys
compared with those of MeHg and EtHg likely reﬂect the reduced
entrance of the mercurials into cells in the cysteinyl-complex form.
In fact, when present in the intracellular millieu, MeHg-S-Cys likely
displays analogous toxicity to MeHg given the fast exchange of
MeHg between sulfhydryl molecules (Rabenstein et al., 1982). This
idea is reinforced by the ﬁndings that all the four studied
mercurials (MeHg, EtHg, MeHg-S-Cys and EtHg-S-Cys) caused
signiﬁcant reductions in intracellular GSH levels when incubated
at concentrations approximating their respective EC50 (Fig. 3).
L-Met (a LAT system substrate) signiﬁcantly protected C6 cells
from MeHg-S-Cys induced cell death, but no signiﬁcant protective
effects were observed in the presence of this amino acid when the
cells were treated with MeHg alone (Fig. 2A). In addition, L-Met
signiﬁcantly protected C6 cells from EtHg-S-Cys induced cell
death, but no signiﬁcant protective effects of L-Met were observed
when the cells were treated with EtHg alone (Fig. 2B). As L-Met is a
substrate for LAT-1, these results are in agreement with the
concept that the MeHg-S-Cys complex enters cells, at least in part,
through this transporter. It has been previously shown that MeHg-
Cys administration promotes signiﬁcant Hg uptake in vivo
(Aschner and Clarkson, 1989; Hirayama, 1980) and this effect
was partially abolished by substrates of the LAT transporters
(Aschner and Clarkson, 1989; Kerper et al., 1992). The same
inhibition by LAT substrates in Hg uptake after MeHg-S-Cys
administration was also observed in rat primary astrocyte cultures(Aschner et al., 1990) and cultured brain capillary endothelial cells
(Mokrzan et al., 1995). This transport has been explained by MeHg-
S-Cys mimicking the amino acid methionine, due to their similar
structures (Aschner, 1989). However computational studies
suggested that these two structures (methionine and MeHg-S-
Cys complex) are in fact quite different. It has been proposed that
the transport of MeHg-S-Cys was not related to its mimicry of
methionine, but rather that the transporter LAT recognizes a
speciﬁc region of this complex (Hoffmeyer et al., 2006).
Although we observed that MeHg and MeHg-Cys signiﬁcantly
decreased the ability to reduce MTT in C6 cells, similarly to the
observations made by Roos et al. (2011) in liver slices, cultured C6
cells and liver slices behave differently when exposed to these
mercurials. In fact, Roos et al. (2011) observed a higher Hg uptake
in liver slices exposed to MeHg-Cys compared with those exposed
to MeHg, suggesting a major contribution of the LAT system to the
mercurial’s (MeHg-Cys) entry into liver slices. Accordingly, a
higher rate of reactive oxygen species generation was observed in
MeHg-Cys-exposed liver slices compared with those exposed to
MeHg alone (Roos et al., 2011). Although we observed that L-Met
treatment decreased Hg uptake in C6 cells exposed to MeHg-Cys
(but not in cells exposed to MeHg), a higher Hg uptake was
observed in C6 cells treated with MeHg compared with those
treated with MeHg-Cys. These results indicate that mechanisms
other than the LAT system are signiﬁcantly important for MeHg
entry into C6 cells.
The GSH antioxidant system is the major defense against
oxidative damage in the CNS and a direct relationship between the
GSH redox system and MeHg neurotoxicity has been proposed
(Ballatori and Clarkson, 1982; Shanker et al., 2005; Franco et al.,
2006; Amonpatumrat et al., 2008; Stringari et al., 2008; Ni et al.,
2011). Herein, the four studied mercurials signiﬁcantly reduced
intracellular GSH levels (when added at concentrations approxi-
mating their respective EC50). No differences in GSH levels were
observed between cells treated with MeHg or EtHg. In addition, no
differences were found between cells treated with MeHg-S-Cys or
EtHg-S-Cys. This indicates that not only MeHg and EtHg, but also
their complexes with cysteine, are able to deplete endogenous
GSH. This observation strongly suggests the occurrence of
mercury’s exchange from the sulfur atom of cysteine to thiols
(or thiolate) inherent to biomolecules (see Eq. (1)), corroborating
proton nuclear magnetic resonance studies on mercurial binding
to thiol molecules (Rabenstein et al., 1982). Such exchanges are
likely responsible for the cell toxicities observed after MeHg-S-Cys
and EtHg-S-Cys exposures.
CH3-Hg-S-Cys þ R-S ! Cys-S þ CH3-Hg-S-R (1)
Eq. (1) note: Mercury (as a methylmercury-cysteine complex,
CH3-Hg-S-Cys) exchanges from the sulfur atom of cysteine to a
thiol biomolecule (R-S), generating ‘‘free’’ cysteine (Cys-S) and
the ‘‘oxidized’’ thiol biomolecule (CH3-Hg-S-R). The interaction of
Hg with the thiol group (or thiolate anion) from a biomolecule
might affect its physiological function, leading to toxic conse-
quences. A similar reaction could occur with EtHg-S-Cys complex
(CH3-CH2-Hg-S-Cys) instead of MeHg-S-Cys complex. Analogous
to thiol biomolecules, selenoproteins (R-SeH or R-Se) could also
represent molecular targets, generating products of Hg-Se
interaction (CH3-Hg-Se-R or CH3-CH2-Hg-Se-R).
LAT-1 functions as a bi-directional transporter of amino acids
(Verrey, 2003). It is ubiquitously distributed in various cell types
and tissues, and is highly abundant in brain, placenta and tumors
(del Amo et al., 2008). Previous studies on the expression of LAT-1
(Kanai et al., 1998; Boado et al., 1999; Segawa et al., 1999;
Yanagida et al., 2001) pointed to the heart and brain as tissues that
express low (not detected) and high levels of LAT-1, respectively.
L.T. Zimmermann et al. / NeuroToxicology 38 (2013) 1–8 7Our western blot analyses (Fig. 4) indicates the presence of LAT-1
in C6 glioma cells (used herein as a cellular model to investigate
mercurials’ transport) and in the rodent hippocampus, as well as its
absence from heart tissue, corroborating prior ﬁndings by means of
northern blot analyses (Kanai et al., 1998; Boado et al., 1999). The
presence of LAT-1 in the rat C6 glioma cell line corroborates our
data on the protective effects of L-Met against MeHg-S-Cys-
induced toxicity. Based on the protective effects of L-Met against
EtHg-S-Cys-induced toxicity, the positive detection of LAT-1 in C6
cells also reinforces the hypothesis that EtHg-S-Cys is also a
substrate for this transporter system.
In conclusion, in the present study we investigated and
compared the toxicity of different Hg compounds (MeHg, EtHg,
MeHg-S-Cys and EtHg-S-Cys) in C6 glioma cells. Mercurial
complexes with Cys appeared to be less toxic to C6 cells than
MeHg or EtHg alone. The lower toxicities in the presence of MeHg-
S-Cys or EtHg-S-Cys (compared with MeHg and EtHg) appear to be
related to reduced mercurial entrance into the cells. In addition,
treatment with L-Met was cytoprotective against MeHg-S-Cys and
EtHg-S-Cys cytotoxicity, but not against MeHg and EtHg (data
corroborated by Hg and GSH levels). Our data indicate that L-Met
prevents MeHg-S-Cys- and EtHg-S-Cys-induced cytotoxicity sec-
ondary to attenuated mercurial entry into cells via the LAT
transporter system. Thus, the results indicate that the uptake of
MeHg-S-Cys and EtHg-S-Cys into C6 cells is mediated, at least in
part, via the LAT system. Although the relationship between
toxicity and MeHg-cysteine complexation is a relatively well
studied topic (Yin et al., 2008; Roos et al., 2010, 2011), data on the
relationship between toxicity and EtHg-cysteine complexation is
scarce. In this context, the results obtained with EtHg-Cys in C6
cells represent a signiﬁcant novelty concerning the toxicity elicited
by this organic mercurial. When extrapolated to in vivo conditions,
our results suggest that endogenous thiols likely inﬂuence the
entry of EtHg into cells expressing LAT. With respect to MeHg and
EtHg, even though both mercurials showed similar toxicities in C6
cells, the results cannot be directly extrapolated to in vivo
conditions. In fact, the toxic potential of MeHg under in vivo
conditions is higher than that of EtHg (Burbacher et al., 2005),
which might be a consequence of differential metabolism path-
ways and excretion rates, and consequently its half-life.
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